España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Crinetics Pharmaceuticals
CRNX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$40.19
1.43
3.68%
Pre-Market: 8:48 AM EDT
Get Report
Comment
Crinetics Pharmaceuticals (CRNX) Forecast
News
Earnings
Crinetics Pharmaceuticals (CRNX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock
Crinetics Pharmaceuticals Stock (NASDAQ: CRNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor
Jefferies Upgrades Crinetics Pharmaceuticals ...
Benzinga Newsdesk
Monday, January 13, 2025
HC Wainwright & Co. Reiterates Buy on Crineti...
Benzinga Newsdesk
Friday, January 10, 2025
Crinetics Pharmaceuticals Announced Topline R...
Benzinga Newsdesk
Monday, December 16, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Vandana Singh
Monday, December 09, 2024
Crinetics Announces FDA Acceptance Of Its New...
Benzinga Newsdesk
Thursday, November 14, 2024
Crinetics Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Citigroup Maintains Buy on Crinetics Pharmace...
Benzinga Newsdesk
Wednesday, November 13, 2024
HC Wainwright & Co. Maintains Buy on Crinetic...
Benzinga Newsdesk
Tuesday, November 12, 2024
Crinetics Expects That Its Cash & Equivalents...
Benzinga Newsdesk
Crinetics Pharmaceuticals Q3 2024 GAAP EPS $(...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Wednesday, October 09, 2024
Reported Earlier, Crinetics Pharmaceuticals P...
Benzinga Newsdesk
Tuesday, October 08, 2024
Crinetics Pharmaceuticals Announces Proposed ...
Benzinga Newsdesk
Friday, September 27, 2024
What Analysts Are Saying About Crinetics Pharmaceuticals Stock
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, September 26, 2024
Crinetics Submits New Drug Application For Pa...
Benzinga Newsdesk
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Cr...
Benzinga Newsdesk
Friday, August 09, 2024
HC Wainwright & Co. Maintains Buy on Crinetic...
Benzinga Newsdesk
Crinetics Pharmaceuticals shares are trading ...
Benzinga Newsdesk
A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
Benzinga Insights
Oppenheimer Reiterates Outperform on Crinetic...
Benzinga Newsdesk
Thursday, August 08, 2024
Crinetics Expects Cash & Equivalents To Be Su...
Benzinga Newsdesk
Crinetics Says Marc Wilson Will Be Transition...
Benzinga Newsdesk
Crinetics Pharmaceuticals Q2 2024 GAAP EPS $(...
Benzinga Newsdesk
Sunday, July 14, 2024
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Lekha Gupta
Tuesday, July 09, 2024
Crinetics Pharmaceuticals shares are trading ...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Crinetics P...
Benzinga Newsdesk
Tuesday, July 02, 2024
Piper Sandler Maintains Overweight on Crineti...
Benzinga Newsdesk
Monday, July 01, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, June 28, 2024
Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Crineti...
Benzinga Newsdesk
Tuesday, June 04, 2024
Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Crinetics...
Benzinga Newsdesk
17 Analysts Have This To Say About Crinetics Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Crineti...
Benzinga Newsdesk
Monday, June 03, 2024
Crinetics To Present New Data Results Of The ...
Benzinga Newsdesk
Thursday, May 23, 2024
Baird Maintains Outperform on Crinetics Pharm...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Crinet...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Crineti...
Benzinga Newsdesk
Wednesday, May 22, 2024
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Market-Moving News for May 22nd
Benzinga Newsdesk
Crinetics Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Crinetics Pharmaceuticals Announces ENDO 2024...
Benzinga Newsdesk
Tuesday, May 14, 2024
18 Analysts Have This To Say About Crinetics Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Cr...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on Crineti...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
